Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition Post author: Post published:May 20, 2024 Post category:uncategorized Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models. You Might Also Like COVID-19 causes lasting cognitive impairment tied to brain injury markers September 25, 2024 Monk Fruit 101: A Complete Guide November 16, 2023 Innovative collar device for detecting sleep apnea in dogs at home June 20, 2024